Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block Versus Placebo to Manage Anxiety at Electronic Dance Music Festivals
NCT05729503Phase 2Withdrawn
- Sponsor
- University of Calgary
- Start
- May 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in anxiety disorder, sponsored by University of Calgary. Planned start May 2026; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05729503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729503.